The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Good momentum in commercial CDMO business
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
Subscribe To Our Newsletter & Stay Updated
